HIGH-DOSE CYCLOPHOSPHAMIDE - AN EFFECTIVE TREATMENT FOR ADVANCED REFRACTORY MULTIPLE-MYELOMA

被引：0
作者：
LENHARD, RE
OKEN, MM
BARNES, JM
HUMPHREY, RL
GLICK, JH
SILVERSTEIN, MN
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
[2] SIDNEY FARBER CANC INST,BOSTON,MA 02115
[3] UNIV PENN,PHILADELPHIA,PA 19104
[4] MAYO CLIN,ROCHESTER,MN
来源：
CANCER | 1984年 / 53卷 / 07期
关键词：
D O I：
10.1002/1097-0142(19840401)53:7<1456::AID-CNCR2820530705>3.0.CO;2-C
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1456 / 1460
页数：5
相关论文
共 50 条
[31]   HIGH-RISK MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE MELPHALAN [J].
LOKHORST, HM ;
MEUWISSEN, OJAT ;
VERDONCK, LF ;
DEKKER, AW .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :47-51
[32]   High-Dose Cyclophosphamide in the Treatment of Multiple Sclerosis [J].
Schwartzman, Robert Jay ;
Simpkins, Nicole ;
Alexander, Guillermo M. ;
Reichenberger, Erin ;
Ward, Kristine ;
Lindenberg, Noah ;
Topolsky, David ;
Crilley, Pam .
CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (02) :118-127
[33]   Effective mobilization of stem cells in multiple myeloma following priming by high-dose cyclophosphamide and bortezomib [J].
Reti, M. ;
Mikala, G. ;
Goda, V. ;
Janosi, J. ;
Peto, M. ;
Masszi, T. .
BLOOD REVIEWS, 2007, 21 :S90-S90
[34]   High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis [J].
Gladstone, Douglas E. ;
Zamkoff, Kenneth W. ;
Krupp, Lauren ;
Peyster, Robert ;
Sibony, Patrick ;
Christodoulou, Christopher ;
Locher, Emily ;
Coyle, Patricia K. .
ARCHIVES OF NEUROLOGY, 2006, 63 (10) :1388-1393
[35]   HIGH-DOSE MELPHALAN AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR REFRACTORY MULTIPLE-MYELOMA [J].
BARLOGIE, B ;
JAGANNATH, S ;
DIXON, DO ;
CHESON, B ;
SMALLWOOD, L ;
HENDRICKSON, A ;
PURVIS, JD ;
BONNEM, E ;
ALEXANIAN, R .
BLOOD, 1990, 76 (04) :677-680
[36]   HIGH-DOSE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA - IMPROVED PROGNOSIS WITH BETTER SUPPORTIVE CARE AND DOUBLE TRANSPLANTS [J].
VESOLE, DH ;
BARLOGIE, B ;
JAGANNATH, S ;
CHESON, B ;
TRICOT, G ;
ALEXANIAN, R ;
CROWLEY, J .
BLOOD, 1994, 84 (03) :950-956
[37]   HEXAMETHYLMELAMINE (HMM) - NEW AGENT EFFECTIVE IN TREATMENT OF REFRACTORY MULTIPLE-MYELOMA [J].
COHEN, HJ .
BLOOD, 1977, 50 (05) :187-187
[38]   INFUSED VINCRISTINE AND ADRIAMYCIN WITH HIGH-DOSE METHYLPREDNISOLONE (VAMP) IN ADVANCED PREVIOUSLY TREATED MULTIPLE-MYELOMA PATIENTS [J].
FORGESON, GV ;
SELBY, P ;
LAKHANI, S ;
ZULIAN, G ;
VINER, C ;
MAITLAND, J ;
MCELWAIN, TJ .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :469-473
[39]   IDIOTYPIC IMMUNOGLOBULIN AS AN INDICATOR OF RESIDUAL DISEASE IN MULTIPLE-MYELOMA FOLLOWING TREATMENT WITH HIGH-DOSE MELPHALAN [J].
THOMPSON, J ;
SELBY, P ;
ANDERSON, V ;
MCELWAIN, TJ ;
STEVENSON, GT .
BRITISH JOURNAL OF CANCER, 1987, 55 (03) :345-345
[40]   High-dose cyclophosphamide in the treatment of aggressive multiple sclerosis [J].
Krishnan, C ;
Drachman, D ;
McArthur, J ;
Irani, D ;
Nath, A ;
Pardo-Villamizar, C ;
Yousem, D ;
Brodsky, R ;
Calabresi, P ;
Kerr, DA .
NEUROLOGY, 2006, 66 (05) :A30-A30
12345